Compare IART & GSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IART | GSBD |
|---|---|---|
| Founded | 1989 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 1995 | N/A |
| Metric | IART | GSBD |
|---|---|---|
| Price | $13.23 | $10.08 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 7 | 1 |
| Target Price | ★ $15.00 | $9.00 |
| AVG Volume (30 Days) | 874.9K | ★ 1.3M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 12.70% |
| EPS Growth | N/A | ★ 69.72 |
| EPS | N/A | ★ 1.14 |
| Revenue | ★ $1,642,966,000.00 | $383,307,000.00 |
| Revenue This Year | $3.26 | N/A |
| Revenue Next Year | $2.71 | N/A |
| P/E Ratio | ★ N/A | $8.83 |
| Revenue Growth | ★ 4.99 | N/A |
| 52 Week Low | $10.87 | $9.35 |
| 52 Week High | $27.13 | $13.45 |
| Indicator | IART | GSBD |
|---|---|---|
| Relative Strength Index (RSI) | 53.66 | 57.91 |
| Support Level | $12.81 | $9.81 |
| Resistance Level | $13.43 | $10.25 |
| Average True Range (ATR) | 0.57 | 0.17 |
| MACD | 0.24 | 0.07 |
| Stochastic Oscillator | 78.69 | 80.00 |
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests primarily in U.S. middle-market companies such as banks and the public debt markets. The company focuses on the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.